Welcome to Labeled Immunoassays and Clinical Medicine website!
The Comparison of Clinical Efficacy, Fusion Gene,Serum Markers and Prognosis of Crizotinib and Non-crizotinib treatment for EML4-ALK Positive  Patients with Non Small Cell Lung Cancer
WU Li
Labeled Immunoassays and Clinical Medicine . 2018, (11): 1650 -1653 .  DOI: 10.11748/bjmy.issn.1006-1703.2018.11.018

京ICP备18063657号-1
Copyright © Labeled Immunoassays and Clinical Medicine, All Rights Reserved.
Tel: 010-68515701,68517801　Fax: 010-68533122　E-mail: bjmy@circ.com.cn
Powered by Beijing Magtech Co., Ltd.